Work

rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression

Year: 2021

Type: article

Source: Gene Therapy

DOI: 10.1038/s41434-021-00275-5

Authors: Jianzhong Ai, Jia Li, Qin Su, Hong Ma, Ran He, Qiang Wei, Hong Li, Guangping Gao

Institutions: University of Massachusetts Chan Medical School, Sichuan University, West China Hospital of Sichuan University

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Foundation for the National Institutes of Health, National Natural Science Foundation of China, Sichuan University, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke

Awards: New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency, G1854802713, G1900901469, G2467788040, G4020023584, Next Generation of Recombinant AAV Serotype For Gene Therapy, G5444395973, G6344557060, A Gene therapeutic approach to stable suppression of HIV-1 replication, G7460861305, G8089287157, Develop combinatorial non-viral and viral CRISPR delivery for lung diseases, Develop combinatorial non-viral and viral CRISPR delivery for lung diseases, G8935022741, G8979051822, Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and Leukodystrophies

OpenAlex ID: W3178308058

FWCI: 0.564

Cites: 35

Cited by: 7

Related to: 10